ID

14405

Beschreibung

A Comparison of Levalbuterol Plus Ipratropium With Levalbuterol Alone in the Treatment of Acute Asthma Exacerbation; ODM derived from: https://clinicaltrials.gov/show/NCT00583778

Link

https://clinicaltrials.gov/show/NCT00583778

Stichworte

  1. 13.04.16 13.04.16 -
Rechteinhaber

CC BY-NC 3.0

Hochgeladen am

13. April 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Asthma NCT00583778

Eligibility Asthma NCT00583778

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00583778
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
18-45 years of age
Beschreibung

age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
history of asthma
Beschreibung

asthma

Datentyp

boolean

Alias
UMLS CUI [1]
C0004096
fev1 > 50% of predicted for their height, age, gender and race upon presentation to the ed
Beschreibung

fev1

Datentyp

boolean

Alias
UMLS CUI [1]
C0748133
no other cause of wheezing or shortness of breath except for asthma as determined by the investigator
Beschreibung

no other cause of wheezing or shortness of breath

Datentyp

boolean

Alias
UMLS CUI [1]
C0043144
UMLS CUI [2]
C0013404
no history of glaucoma
Beschreibung

glaucoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0017601
no ipratropium or other anticholinergics within 6 hours of study
Beschreibung

ipratropium or other anticholinergics

Datentyp

boolean

Alias
UMLS CUI [1]
C0700580
UMLS CUI [2]
C0242896
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
subjects who, in the investigator's opinion, have life-threatening asthma requiring emergent intervention precluding the ability to complete the treatments during the treatment period
Beschreibung

life-threatening asthma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C2826244
UMLS CUI [2]
C0013956
based upon history or physical exam in the ed orclinic, subjects with known or suspected cause of pulmonary symptoms other than asthma, such as copd, chf, pneumonia, pulmonary embolism, or angioedema
Beschreibung

respiratory disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0035204
subject with a known sensitivity to levalbuterol or racemic albuterol
Beschreibung

sensitivity to levalbuterol or racemic albuterol

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0772501
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C2957898
known 20 pack year smoker
Beschreibung

smoking history

Datentyp

boolean

Alias
UMLS CUI [1]
C1519384
UMLS CUI [2]
C1277691
use of ipratropium 6 hours prior to presenting to the ed
Beschreibung

ipratropium

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0700580
UMLS CUI [1,2]
C0040223
subject who may be pregnant or is pregnant es evidenced by pregnancy test
Beschreibung

pregnancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0032976

Ähnliche Modelle

Eligibility Asthma NCT00583778

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00583778
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
18-45 years of age
boolean
C0001779 (UMLS CUI [1])
asthma
Item
history of asthma
boolean
C0004096 (UMLS CUI [1])
fev1
Item
fev1 > 50% of predicted for their height, age, gender and race upon presentation to the ed
boolean
C0748133 (UMLS CUI [1])
no other cause of wheezing or shortness of breath
Item
no other cause of wheezing or shortness of breath except for asthma as determined by the investigator
boolean
C0043144 (UMLS CUI [1])
C0013404 (UMLS CUI [2])
glaucoma
Item
no history of glaucoma
boolean
C0017601 (UMLS CUI [1])
ipratropium or other anticholinergics
Item
no ipratropium or other anticholinergics within 6 hours of study
boolean
C0700580 (UMLS CUI [1])
C0242896 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
life-threatening asthma
Item
subjects who, in the investigator's opinion, have life-threatening asthma requiring emergent intervention precluding the ability to complete the treatments during the treatment period
boolean
C0004096 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
C0013956 (UMLS CUI [2])
respiratory disease
Item
based upon history or physical exam in the ed orclinic, subjects with known or suspected cause of pulmonary symptoms other than asthma, such as copd, chf, pneumonia, pulmonary embolism, or angioedema
boolean
C0035204 (UMLS CUI [1])
sensitivity to levalbuterol or racemic albuterol
Item
subject with a known sensitivity to levalbuterol or racemic albuterol
boolean
C0020517 (UMLS CUI [1,1])
C0772501 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C2957898 (UMLS CUI [2,2])
smoking history
Item
known 20 pack year smoker
boolean
C1519384 (UMLS CUI [1])
C1277691 (UMLS CUI [2])
ipratropium
Item
use of ipratropium 6 hours prior to presenting to the ed
boolean
C0700580 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
pregnancy
Item
subject who may be pregnant or is pregnant es evidenced by pregnancy test
boolean
C0032961 (UMLS CUI [1])
C0032976 (UMLS CUI [2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video